These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 12509401

  • 1. Essential role of phosphatidylinositol 3-kinase-dependent CCAAT/enhancer binding protein beta activation in the induction of glutathione S-transferase by oltipraz.
    Kang KW, Cho IJ, Lee CH, Kim SG.
    J Natl Cancer Inst; 2003 Jan 01; 95(1):53-66. PubMed ID: 12509401
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.
    Lee SJ, Kim SG.
    Mol Pharmacol; 2006 Jan 01; 69(1):385-96. PubMed ID: 16246908
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
    Park EY, Cho IJ, Kim SG.
    Cancer Res; 2004 May 15; 64(10):3701-13. PubMed ID: 15150131
    [Abstract] [Full Text] [Related]

  • 6. Oltipraz inhibits 3-methylcholanthrene induction of CYP1A1 by CCAAT/enhancer-binding protein activation.
    Cho IJ, Kim SG.
    J Biol Chem; 2003 Nov 07; 278(45):44103-12. PubMed ID: 12941938
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.
    Ki SH, Cho IJ, Choi DW, Kim SG.
    Mol Cell Biol; 2005 May 07; 25(10):4150-65. PubMed ID: 15870285
    [Abstract] [Full Text] [Related]

  • 9. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
    Cho IJ, Ki SH, Brooks C, Kim SG.
    Xenobiotica; 2009 Feb 07; 39(2):182-92. PubMed ID: 19255944
    [Abstract] [Full Text] [Related]

  • 10. Oltipraz promotion of liver regeneration after partial hepatectomy: The role of PI3-kinase-dependent C/EBPbeta and cyclin E regulation.
    Cho IJ, Sung DK, Kang KW, Kim SG.
    Arch Pharm Res; 2009 Apr 07; 32(4):625-35. PubMed ID: 19407981
    [Abstract] [Full Text] [Related]

  • 11. Phase II enzyme induction by alpha-lipoic acid through phosphatidylinositol 3-kinase-dependent C/EBPs activation.
    Ki SH, Kim SG.
    Xenobiotica; 2008 Jun 07; 38(6):587-604. PubMed ID: 18570160
    [Abstract] [Full Text] [Related]

  • 12. Ceramide negatively regulates glutathione S-transferase gene transactivation via repression of hepatic nuclear factor-1 that is degraded by the ubiquitin proteasome system.
    Park IN, Cho IJ, Kim SG.
    Mol Pharmacol; 2004 Jun 07; 65(6):1475-84. PubMed ID: 15155840
    [Abstract] [Full Text] [Related]

  • 13. Differential hepatic GSTA2 expression of arylalkyl isothiocyanates in vivo and in vitro: the molecular mechanism of gene induction by phenethyl isothiocyanate.
    Gum SI, Cho MK.
    Mol Nutr Food Res; 2013 Dec 07; 57(12):2223-32. PubMed ID: 24039128
    [Abstract] [Full Text] [Related]

  • 14. Regulation of the rat glutathione S-transferase A2 gene by glucocorticoids: crosstalk through C/EBPs.
    Falkner KC, Prough RA.
    Drug Metab Rev; 2007 Dec 07; 39(2-3):401-18. PubMed ID: 17786629
    [Abstract] [Full Text] [Related]

  • 15. NF-kappaB activation by the chemopreventive dithiolethione oltipraz is exerted through stimulation of MEKK3 signaling.
    Nho CW, O'Dwyer PJ.
    J Biol Chem; 2004 Jun 18; 279(25):26019-27. PubMed ID: 15047705
    [Abstract] [Full Text] [Related]

  • 16. ERK1 and ERK2 activate CCAAAT/enhancer-binding protein-beta-dependent gene transcription in response to interferon-gamma.
    Hu J, Roy SK, Shapiro PS, Rodig SR, Reddy SP, Platanias LC, Schreiber RD, Kalvakolanu DV.
    J Biol Chem; 2001 Jan 05; 276(1):287-97. PubMed ID: 10995751
    [Abstract] [Full Text] [Related]

  • 17. Cell-based studies reveal differences in glutathione S-transferase induction between oltipraz and tert-butylhydroquinone.
    Lamb JG, Franklin MR.
    J Biochem Mol Toxicol; 2002 Jan 05; 16(4):154-61. PubMed ID: 12242683
    [Abstract] [Full Text] [Related]

  • 18. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
    Noh K, Kim YM, Kim YW, Kim SG.
    Drug Metab Dispos; 2011 Aug 05; 39(8):1451-9. PubMed ID: 21596890
    [Abstract] [Full Text] [Related]

  • 19. Hepatocyte growth factor activates CCAAT enhancer binding protein and cell replication via PI3-kinase pathway.
    Cho MK, Kim SG.
    Hepatology; 2003 Mar 05; 37(3):686-95. PubMed ID: 12601366
    [Abstract] [Full Text] [Related]

  • 20. Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation.
    Bae EJ, Kim SG.
    Mol Pharmacol; 2005 Sep 05; 68(3):660-9. PubMed ID: 15961673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.